Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2009 1
2010 4
2011 2
2012 4
2013 4
2015 3
2016 16
2017 26
2018 15
2019 11
2020 9
2021 5
2022 12
2023 15
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Establishment of patient-derived organoid models of lower-grade glioma.
Abdullah KG, Bird CE, Buehler JD, Gattie LC, Savani MR, Sternisha AC, Xiao Y, Levitt MM, Hicks WH, Li W, Ramirez DMO, Patel T, Garzon-Muvdi T, Barnett S, Zhang G, Ashley DM, Hatanpaa KJ, Richardson TE, McBrayer SK. Abdullah KG, et al. Among authors: garzon muvdi t. Neuro Oncol. 2022 Apr 1;24(4):612-623. doi: 10.1093/neuonc/noab273. Neuro Oncol. 2022. PMID: 34850183 Free PMC article.
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation.
Guo G, Gong K, Beckley N, Zhang Y, Yang X, Chkheidze R, Hatanpaa KJ, Garzon-Muvdi T, Koduru P, Nayab A, Jenks J, Sathe AA, Liu Y, Xing C, Wu SY, Chiang CM, Mukherjee B, Burma S, Wohlfeld B, Patel T, Mickey B, Abdullah K, Youssef M, Pan E, Gerber DE, Tian S, Sarkaria JN, McBrayer SK, Zhao D, Habib AA. Guo G, et al. Among authors: garzon muvdi t. Nat Cell Biol. 2022 Aug;24(8):1291-1305. doi: 10.1038/s41556-022-00962-4. Epub 2022 Aug 1. Nat Cell Biol. 2022. PMID: 35915159 Free PMC article.
Management of Nonfunctioning Recurrent Pituitary Adenomas.
Farrell CJ, Garzon-Muvdi T, Fastenberg JH, Nyquist GG, Rabinowitz MR, Rosen MR, Evans JJ. Farrell CJ, et al. Among authors: garzon muvdi t. Neurosurg Clin N Am. 2019 Oct;30(4):473-482. doi: 10.1016/j.nec.2019.05.006. Epub 2019 Aug 7. Neurosurg Clin N Am. 2019. PMID: 31471054 Review.
Intraoperative imaging techniques for glioma surgery.
Garzon-Muvdi T, Kut C, Li X, Chaichana KL. Garzon-Muvdi T, et al. Future Oncol. 2017 Aug;13(19):1731-1745. doi: 10.2217/fon-2017-0092. Epub 2017 Aug 10. Future Oncol. 2017. PMID: 28795843 Free PMC article. Review.
Biomarkers and Immunotherapeutic Targets in Glioblastoma.
Hung AL, Garzon-Muvdi T, Lim M. Hung AL, et al. Among authors: garzon muvdi t. World Neurosurg. 2017 Jun;102:494-506. doi: 10.1016/j.wneu.2017.03.011. Epub 2017 Mar 12. World Neurosurg. 2017. PMID: 28300714 Review.
A Compartmentalized Classification for Sphenoorbital Meningiomas.
Zohdy YM, Solares CA, Pradilla G, Garzon-Muvdi T. Zohdy YM, et al. Among authors: garzon muvdi t. World Neurosurg. 2023 Nov 20:S1878-8750(23)01650-9. doi: 10.1016/j.wneu.2023.11.086. Online ahead of print. World Neurosurg. 2023. PMID: 37992990 No abstract available.
Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence.
Traylor JI, Pernik MN, Plitt AR, Lim M, Garzon-Muvdi T. Traylor JI, et al. Among authors: garzon muvdi t. Cancers (Basel). 2021 May 17;13(10):2408. doi: 10.3390/cancers13102408. Cancers (Basel). 2021. PMID: 34067530 Free PMC article. Review.
Basis for Immunotherapy for Treatment of Meningiomas.
Garzon-Muvdi T, Bailey DD, Pernik MN, Pan E. Garzon-Muvdi T, et al. Front Neurol. 2020 Aug 28;11:945. doi: 10.3389/fneur.2020.00945. eCollection 2020. Front Neurol. 2020. PMID: 32982948 Free PMC article. Review.
Animal models of neurological disease.
Shah A, Garzon-Muvdi T, Mahajan R, Duenas VJ, Quiñones-Hinojosa A. Shah A, et al. Among authors: garzon muvdi t. Adv Exp Med Biol. 2010;671:23-40. doi: 10.1007/978-1-4419-5819-8_3. Adv Exp Med Biol. 2010. PMID: 20455493 Review.
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
Medina EJ, Zohdy YM, Porto E, Revuelta Barbero JM, Bray D, Maldonado J, Rodas A, Mayol M, Morales B, Neill S, Read W, Pradilla G, Ioachimescu A, Garzon-Muvdi T. Medina EJ, et al. Among authors: garzon muvdi t. Front Endocrinol (Lausanne). 2023 Jul 17;14:1195792. doi: 10.3389/fendo.2023.1195792. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37529607 Free PMC article. Review.
114 results